Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STX vs MRNA✓SelectedUSD · MRNASTX vs MRNA performance historyLatest closeAs of-3.09%11/13
Stock and ETF performance explorer

STX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+673.8%
MRNA return
+221.0%
Excess return
+452.8%
Maximum drawdown
-57.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.1%-3.4%+0.4%-3.0%
7D+14.6%-12.1%+26.7%+14.9%
30D-26.0%-1.3%-24.7%-25.9%
3M-42.6%+250.9%-293.6%-43.8%
6M-35.3%+343.0%-378.3%-40.1%
YTD+92.5%+657.4%-565.0%+61.0%
1Y+102.4%+794.9%-692.5%+64.5%
3Y+673.8%+218.1%+455.7%+562.5%
All+673.8%+221.0%+452.8%+562.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling